Loading…


Back to Linked Studies

Name of Funded Study:UCLA Consortium for Neuropsychiatric Phenomics
PhenX Protocols: Hypomania/Mania Symptoms - Adult(PX120402)
Depression - Adult(PX120502)
Eating Disorder Screener for DSM-IV(PX120601)
Symptoms of Autism Spectrum Disorders - Adult(PX120901)
Personality Traits(PX121101)
General Distress Screener(PX121301)
Attention-Deficit Hyperactivity Disorder Symptoms - Adult(PX121501)
Psychopathy - Adult(PX121601)
Global Mental Status Screener - Adult(PX130701)
Verbal Memory - Adult(PX130801)
Visual Memory - Adult(PX130901)
Executive Function(PX131101)
Acculturation(PX180101)
Disinhibiting Behaviors - Impulsivity - Adolescent and Adult(PX180401)
Emotional State - Adult(PX180501)
General Self-Efficacy - Adult(PX180601)
Perceived Social Support Conflict(PX180701)
Perceived Stress(PX180801)
Self-esteem(PX180901)
Social Isolation(PX181001)
Study Acronym:
Principal Investigator:Robert Bilder, PhD
Primary Contact Name:-
Primary Contact Email:-
Number Participants: 100-499
Grant Number:
Study Stage: Data analysis
Primary Research Focus:The Consortium for Neuropsychiatric Phenomics comprises 8 linked grants awarded under the aegis of the NIH Roadmap Initiative. The PhenX supplement grant was awarded to the Human Translational Applications Core, a center core that conducted extensive phenotyping of more than 1000 healthy volunteers aged 21 to 50 in the Los Angeles metropolitan area from 2007 to 2012. The phenotyping efforts focused on two primary themes - memory mechanisms and response inhibition mechanisms - and participants completed approximately 12 hours of cognitive phenotyping, and a subset of these participants received also several hours of neuroimaging procedures to examine brain structure and function (descriptions of these procedures are available at www.phenomics.ucla.edu).
Study Design: Case control
Funding Period:2011-2013
Registration Date:19-SEP-13